? 澳门皇冠体育代理,澳门皇家开户网址_北京恫搜工程有限公司 澳门皇冠体育代理欢迎您!
澳门皇冠体育代理:新冠或没有特效药

Teikoku Pharma USA located in San Jose California and headquartered in Kagawa Japan, is a pharmaceutical company focused on the 研究与开发 of treatments for CNS, Pain 管理 and Oncology.? Founded in 1997, the company successfully developed?Lidocaine 5% patch worldwide under Lidoderm?, Lidotop??and? Versatis? brands.? To date, 2 billion Lidocaine 5% patches have been distributed in 59 countries.??TPU recently also received NDA approval for?非酒精多西他赛注射液 currently available in the US.

May 30, 2018

Teikoku Pharma USA and Link Health Enter into License Agreement for Lidoderm? in China
SAN JOSE, Calif.,May 30, 2018--Teikoku Pharma USA Inc. (“TPU”) today announced that it has entered into an exclusive license agreement with Link Health Group LTD (“Link Health”) to develop market, sell, and distribute TPU’s flagship product, Lidoderm?, in China. Lidoderm? offers relief of the pain associated with post-herpetic neuralgia (“PHN”). It is a combination of lidocaine in a soft hydrogel plaster combining efficacious treatment with proven tolerability, safety and simple handling.

阅读更多 | 查看全部

Teikoku is building a robust pipeline of drug candidates which may expand the reach and benefit of existing therapeutics. ??

详细了解我们的管道。

Teikoku USA在市场上有两种FDA和一种EMEA批准的产品。
了解有关我们认可产品的更多信息。

We employ our 亲水胶, 矩阵 and other?drug delivery?technologies to expand our product pipeline.
学到更多 About Our Technologies.

友情链接: 搜狗   百度   神马   澳门皇冠体育代理   baiduxml